Inventor · disambiguated record
Falko-Günter Falkner
Also filed as: FALKNER FALKO G · FALKNER FALKO-GUENTER · FALKNER FALKO-GUNTER · Falkner Falko-Günter
16 granted patents·4 pending applications·374 citations·filing 1991–2022
94Inventor score
Top patents by PatentIndex Score
20 records- 0193US5770212ARecombinant poxviruses with foreign DNA in essential regionsIMMUNO AG·Filed 1997·Granted Jun 23, 1998·123 cites·19 claims
- 0292US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 0385US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 0480US5670367ARecombinant fowlpox virusIMMUNO AG·Filed 1994·Granted Sep 23, 1997·53 cites·9 claims
- 0578US6103244AMethods for generating immune responses employing modified vaccinia of fowlpox virusesBAXTER AG·Filed 1996·Granted Aug 15, 2000·36 cites·14 claims
- 0678US5766882Arecombinant poxviruses with foreign DNA in essential regionsIMMUNO AG·Filed 1996·Granted Jun 16, 1998·42 cites·44 claims
- 0777US9463237B2Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A virusesFalkner Falko-Günter·Filed 2012·Granted Oct 11, 2016·4 cites·3 claims
- 0877US6086871AProthrombin derivativesBAXTER AG·Filed 1996·Granted Jul 11, 2000·39 cites·22 claims
- 0976US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 1074US2022213172A1Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia aTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1173US11254731B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 1273US5445953ADirect molecular cloning of a modified poxvirus genomeIMMUNO AG·Filed 1991·Granted Aug 29, 1995·41 cites·26 claims
- 1370US11492388B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 1467US6265183B1Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteinsBAXTER AG·Filed 1994·Granted Jul 24, 2001·23 cites·17 claims
- 1562US10329583B2Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A virusesOLOGY BIOSERVICES INC·Filed 2016·Granted Jun 25, 2019·1 cites·17 claims
- 1662US2021128700A1Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia bBAXALTA INC·Filed 2020·Application pending·0 cites
- 1753US2014255440A1Recombinant viral vectors and methods for inducing an immune response to yellow fever virusBAXTER INT·Filed 2014·Application pending·0 cites
- 1845US2012328649A1Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever VirusFALKNER FALKO-GUENTER·Filed 2011·Application pending·0 cites
- 1935US6077691AHigh level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigenBAXTER AG·Filed 1997·Granted Jun 20, 2000·2 cites·18 claims
- 2030US6004561AHigh level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigenBAXTER AG·Filed 1997·Granted Dec 21, 1999·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →